A carregar...
Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies
This study traces the use of the anticancer drug capecitabine through its loss of patent protection to evaluate the effect of generic pricing on the cost of oral anticancer drugs.
Na minha lista:
| Publicado no: | JAMA Intern Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5820701/ https://ncbi.nlm.nih.gov/pubmed/28892541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.2788 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|